Login Register Cart 0
Generic placeholder image

Anti-Infective Agents

Editor-in-Chief

ISSN (Print): 2211-3525
ISSN (Online): 2211-3533

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Antibacterial Effects of Derivatives of Porphyrin, Naphthalene diimide, Aminophenol and Benzodioxane on Methicillin Resistant Staphylococcus aureus and Neuropathogenic Escherichia coli K1

Author(s): Ruqaiyyah Siddiqui*, Ayaz Anwar, Salwa Ali and Naveed Ahmed Khan

Volume 18, Issue 3, 2020

Page: [275 - 284] Pages: 10

DOI: 10.2174/2211352517666190628111232

Abstract

Background: Infectious diseases contribute to substantial mortality and morbidity worldwide despite advances in therapeutic intervention highlighting the need to identify drugs with antimicrobial properties.

Methods: Here, we utilised several compounds from the following classes: porphyrin, naphthalene diimide, aminophenol derivatives, and benzodioxane, and evaluated their antibacterial activities. Bactericidal and bacteriostatic activity of these compounds were determined against methicillinresistant Staphylococcus aureus (MRSA) and Escherichia coli K1 with various concentrations of the drugs. Moreover, the ability of the bacteria to bind/associate to host cells was also ascertained in the absence and presence of aforementioned compounds.

Results: The results revealed that porphyrin derivative (AYTHPP) had potent effects against MRSA, abolishing viability and blocking binding to the host cells. Importantly, novel AYTHPP exhibited powerful effects against MRSA even though it was not photoactivated. In contrast, other compounds, including naphthalene diimide, acetamol derivatives and benzodioxane, showed no inhibitory effects.

Conclusion: The mechanism of action of porphyrin is likely through the production of reactive oxygen species causing oxidative stress, leading to apoptosis and/or necrosis via perturbations in the plasma membrane. Future studies will determine their in vivo efficacy together will associated molecular mode of action.

Keywords: Infectious diseases, chemotherapy, bactericidal, bacteriostatic, MRSA, E. coli.

Graphical Abstract

[1]
Mortality and global health estimates. Geneva, Switzerland: World Health Organization., 2013. Available from: https://www.who.int/healthinfo/glob-al_burden_disease/en/
[2]
WHO/The top 10 causes of death, 2018. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/index2.html
[3]
Zaidi, A.K.; Awasthi, S.; deSilva, H.J. Burden of infectious diseases in South Asia. BMJ, 2004, 328(7443), 811-815.
[http://dx.doi.org/10.1136/bmj.328.7443.811] [PMID: 15070639]
[4]
Mackey, T.K.; Liang, B.A.; Cuomo, R.; Hafen, R.; Brouwer, K.C.; Lee, D.E. Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment. Clin. Microbiol. Rev., 2014, 27(4), 949-979.
[http://dx.doi.org/10.1128/CMR.00045-14] [PMID: 25278579]
[5]
Khan, N.A.; Siddiqui, R. War on terror cells: killing the host that harbours ‘superbugs’ is an infection control strategy in our fight against infectious diseases. Pathog. Glob. Health, 2014, 108(1), 4-10.
[http://dx.doi.org/10.1179/2047773213Y.0000000125] [PMID: 24548155]
[6]
Gould, I.M.; Bal, A.M. New antibiotic agents in the pipeline and how they can help overcome microbial resistance. Virulence, 2013, 4(2), 185-191.
[http://dx.doi.org/10.4161/viru.22507] [PMID: 23302792]
[7]
Hamblin, M.R.; Hasan, T. Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci., 2004, 3(5), 436-450.
[http://dx.doi.org/10.1039/b311900a] [PMID: 15122361]
[8]
Huang, L.; Dai, T.; Hamblin, M.R. Antimicrobial photodynamic inactivation and photodynamic therapy for infections. Photodynamic Ther-apy: Methods and Protocols; Humana Press: Totowa, 2010, pp. 155-173.
[9]
Zhang, Y.Y.; Zhou, C.H. Synthesis and activities of naphthalimide azoles as a new type of antibacterial and antifungal agents. Bioorg. Med. Chem. Lett., 2011, 21(14), 4349-4352.
[http://dx.doi.org/10.1016/j.bmcl.2011.05.042] [PMID: 21669530]
[10]
Křen, V.; Walterová, D. Silybin and silymarin--new effects and applications. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub., 2005, 149(1), 29-41.
[http://dx.doi.org/10.5507/bp.2005.002] [PMID: 16170386]
[11]
Gazák, R.; Walterová, D.; Kren, V. Silybin and silymarin--new and emerging applications in medicine. Curr. Med. Chem., 2007, 14(3), 315-338.
[http://dx.doi.org/10.2174/092986707779941159] [PMID: 17305535]
[12]
Rao, V., Ed.; Phytochemicals: a global perspective of their role in nutrition and health; InTech: Rijeka, 2012.
[http://dx.doi.org/10.5772/1387]
[13]
Bergman, K.; Müller, L.; Teigen, S.W. Series: current issues in mutagenesis and carcinogenesis, No. 65. The genotoxicity and carcinogenicity of paracetamol: a regulatory (re)view. Mutat. Res., 1996, 349(2), 263-288.
[http://dx.doi.org/10.1016/0027-5107(95)00185-9] [PMID: 8600357]
[14]
Guideline, S.I.G.N. Scottish Intercollegiate Guidelines Network. SIGN Guideline 58: safe sedation of children undergoing diagnostic and therapeutic procedures. Paediatr. Anaesth., 2008, 18(1), 11-12.
[PMID: 18095959]
[15]
American Society of Health-System Pharmacists. (Available from. http://www.ashp.org/)
[16]
Dulon, M.; Haamann, F.; Peters, C.; Schablon, A.; Nienhaus, A. MRSA prevalence in European healthcare settings: a review. BMC Infect. Dis., 2011, 11, 138.
[http://dx.doi.org/10.1186/1471-2334-11-138] [PMID: 21599908]
[17]
Gaschignard, J.; Levy, C.; Bingen, E.; Cohen, R. Epidemiology of Escherichia coli neonatal meningitis. Archives de pediatrie: organe officiel de la Societe francaise de pediatrie,, 2012, 19, S129-S134.
[18]
Jeyamogan, S.; Khan, N.A.; Anwar, A.; Shah, M.R.; Siddiqui, R. Cytotoxic effects of Benzodioxane, Naphthalene diimide, Porphyrin and Acetamol derivatives on HeLa cells. SAGE Open Med., 2018, 62050312118781962
[http://dx.doi.org/10.1177/2050312118781962] [PMID: 30034805]
[19]
Ali, S.M.; Siddiqui, R.; Ong, S.K.; Shah, M.R.; Anwar, A.; Heard, P.J.; Khan, N.A. Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana). Appl. Microbiol. Biotechnol., 2017, 101(1), 253-286.
[http://dx.doi.org/10.1007/s00253-016-7872-2] [PMID: 27743045]
[20]
Khan, N.A.; Osman, K.; Goldsworthy, G.J. Lysates of Locusta migratoria brain exhibit potent broad-spectrum antibacterial activity. J. Antimicrob. Chemother., 2008, 62(3), 634-635.
[http://dx.doi.org/10.1093/jac/dkn239] [PMID: 18552339]
[21]
Khan, N.A.; Siddiqui, R. Acanthamoeba affects the integrity of human brain microvascular endothelial cells and degrades the tight junction proteins. Int. J. Parasitol., 2009, 39(14), 1611-1616.
[http://dx.doi.org/10.1016/j.ijpara.2009.06.004] [PMID: 19580812]
[22]
Rajendran, K.; Anwar, A.; Khan, N.A.; Siddiqui, R. Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri. ACS Chem. Neurosci., 2017, 8(12), 2626-2630.
[http://dx.doi.org/10.1021/acschemneuro.7b00430] [PMID: 29206032]
[23]
Yousuf, F.A.; Yousuf, Z.; Iqbal, J.; Siddiqui, R.; Khan, H.; Khan, N.A. Interactions of neuropathogenic Escherichia coli K1 (RS218) and its derivatives lacking genomic islands with phagocytic Acanthamoeba castellanii and nonphagocytic brain endothelial cells. BioMed Res. Int., 2014, 2014265424
[http://dx.doi.org/10.1155/2014/265424] [PMID: 24818136]
[24]
Kumar, K.; Chopra, S. New drugs for methicillin-resistant Staphylococcus aureus: an update. J. Antimicrob. Chemother., 2013, 68(7), 1465-1470.
[http://dx.doi.org/10.1093/jac/dkt045] [PMID: 23429643]
[25]
Singh, S.; Aggarwal, A.; Bhupathiraju, N.V.; Arianna, G.; Tiwari, K.; Drain, C.M. Glycosylated porphyrins, phthalocyanines, and other porphyrinoids for diagnostics and therapeutics. Chem. Rev., 2015, 115(18), 10261-10306.
[http://dx.doi.org/10.1021/acs.chemrev.5b00244] [PMID: 26317756]
[26]
Malik, Z.; Hanania, J.; Nitzan, Y. Bactericidal effects of photoactivated porphyrins--an alternative approach to antimicrobial drugs. J. Photochem. Photobiol. B, 1990, 5(3-4), 281-293.
[http://dx.doi.org/10.1016/1011-1344(90)85044-W] [PMID: 2115912]
[27]
Maisch, T.; Hackbarth, S.; Regensburger, J.; Felgenträger, A.; Bäumler, W.; Landthaler, M.; Röder, B. Photodynamic inactivation of multi-resistant bacteria (PIB) - a new approach to treat superficial infections in the 21st century. J. Dtsch. Dermatol. Ges., 2011, 9(5), 360-366.
[http://dx.doi.org/10.1111/j.1610-0387.2010.07577.x] [PMID: 21114627]
[28]
Abu-Lail, N.I.; Camesano, T.A. Role of lipopolysaccharides in the adhesion, retention, and transport of Escherichia coli JM109. Environ. Sci. Technol., 2003, 37(10), 2173-2183.
[http://dx.doi.org/10.1021/es026159o] [PMID: 12785523]
[29]
Bonnett, R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem. Soc. Rev., 1995, 24, 19-33.
[http://dx.doi.org/10.1039/cs9952400019]
[30]
Pirota, V.; Nadai, M.; Doria, F.; Richter, S.N. Naphthalene Diimides as Multimodal G-Quadruplex-Selective Ligands. Molecules, 2019, 24(3), 426.
[http://dx.doi.org/10.3390/molecules24030426] [PMID: 30682828]

Rights & Permissions Print Cite
Article Metrics
27
2
© 2024 Bentham Science Publishers | Privacy Policy